A preliminary study to evaluate the effect of intravenous ribavirin treatment on survival rates in Crimean-Congo hemorrhagic fever

J Infect. 2008 Oct;57(4):350-1. doi: 10.1016/j.jinf.2008.07.007. Epub 2008 Aug 22.

Authors

Mustafa Aydin Cevik¹, Nazif Elaldi, Esragül Akinci, Pinar Ongürü, Ayşe Erbay, Turan Buzgan, Ramazan Uzun, Ayhan Kubar, Hürrem Bodur

Affiliation

¹ Ankara Numune Education and Research Hospital, Infectious Diseases and Clinical Microbiology Clinic, Samanpazari, 06100 Ankara, Turkey.

PMID: 18722669
DOI: 10.1016/j.jinf.2008.07.007

No abstract available

Publication types

Letter

MeSH terms

Antiviral Agents* / administration & dosage
Antiviral Agents* / therapeutic use
Case-Control Studies
Hemorrhagic Fever Virus, Crimean-Congo / drug effects
Hemorrhagic Fever, Crimean / drug therapy*
Hemorrhagic Fever, Crimean / mortality*
Hemorrhagic Fever, Crimean / virology
Humans
Injections, Intravenous
Ribavirin* / administration & dosage
Ribavirin* / therapeutic use
Survival Rate
Treatment Outcome
Turkey / epidemiology

Substances

Antiviral Agents
Ribavirin